FDA has questions about Merck's experimental chronic cough drug By: Philadelphia Business Journal via Business Journals January 24, 2022 at 12:13 PM EST The chronic cough drug was approved in Japan, where it will be marketed under the brand name Lyfnua. Read More >>
